These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17805238)

  • 21. [Either calcium carbonate or sevelamer decreases urinary oxalate excretion in chronic renal failure patients].
    Caravaca F; Ruiz AB; Escola JM; Hernández Gallego R; Cerezo I; Fernández N; Barroso S; Martín MV
    Nefrologia; 2007; 27(4):466-71. PubMed ID: 17944584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.
    Chertow GM; Burke SK; Raggi P;
    Kidney Int; 2002 Jul; 62(1):245-52. PubMed ID: 12081584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival in end stage renal disease: calcium carbonate vs. sevelamer.
    Borzecki AM; Lee A; Wang SW; Brenner L; Kazis LE
    J Clin Pharm Ther; 2007 Dec; 32(6):617-24. PubMed ID: 18021340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of MBD parameters in dialysis patients by a switch to, and combined use of lanthanum carbonate: Josai Dialysis Forum collaborative study.
    Shinoda T; Yamasaki M; Chida Y; Takagi M; Tanaka Y; Ando R; Suzuki T; Tagawa H
    Ther Apher Dial; 2013 Apr; 17 Suppl 1():29-34. PubMed ID: 23586510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sevelamer worsens metabolic acidosis in hemodialysis patients.
    De Santo NG; Frangiosa A; Anastasio P; Marino A; Correale G; Perna A; Di Stazio E; Stellato D; Santoro D; Di Meglio E; Iacono G; Ciacci C; Savica V; Cirillo M
    J Nephrol; 2006; 19 Suppl 9():S108-14. PubMed ID: 16736432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
    Suki WN; Zabaneh R; Cangiano JL; Reed J; Fischer D; Garrett L; Ling BN; Chasan-Taber S; Dillon MA; Blair AT; Burke SK
    Kidney Int; 2007 Nov; 72(9):1130-7. PubMed ID: 17728707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: results of a randomized clinical trial.
    Suki WN;
    J Ren Nutr; 2008 Jan; 18(1):91-8. PubMed ID: 18089452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease.
    Russo D; Bellasi A; Pota A; Russo L; Di Iorio B
    J Nephrol; 2015 Feb; 28(1):73-80. PubMed ID: 24599830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of phosphate binder in predialysis patients].
    Taniguchi M
    Clin Calcium; 2009 Feb; 19(2):229-35. PubMed ID: 19182364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lanthanum carbonate delays progression of coronary artery calcification compared with calcium-based phosphate binders in patients on hemodialysis: a pilot study.
    Ohtake T; Kobayashi S; Oka M; Furuya R; Iwagami M; Tsutsumi D; Mochida Y; Maesato K; Ishioka K; Moriya H; Hidaka S
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):439-46. PubMed ID: 23615577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sevelamer is cost-saving vs. calcium carbonate in non-dialysis-dependent CKD patients in italy: a patient-level cost-effectiveness analysis of the INDEPENDENT study.
    Ruggeri M; Cipriani F; Bellasi A; Russo D; Di Iorio B
    Blood Purif; 2014; 37(4):316-24. PubMed ID: 25171148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats.
    Katsumata K; Kusano K; Hirata M; Tsunemi K; Nagano N; Burke SK; Fukushima N
    Kidney Int; 2003 Aug; 64(2):441-50. PubMed ID: 12846739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.
    Lin HH; Liou HH; Wu MS; Lin CY; Huang CC
    Nephrology (Carlton); 2014 Nov; 19(11):672-8. PubMed ID: 25113414
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study.
    Barreto DV; Barreto Fde C; de Carvalho AB; Cuppari L; Draibe SA; Dalboni MA; Moyses RM; Neves KR; Jorgetti V; Miname M; Santos RD; Canziani ME
    Nephron Clin Pract; 2008; 110(4):c273-83. PubMed ID: 19001830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of sevelamer. Comparison with calcium carbonate in the treatment of hyperphosphatemia in hemodialysis patients.
    Shaheen FA; Akeel NM; Badawi LS; Souqiyyeh MZ
    Saudi Med J; 2004 Jun; 25(6):785-91. PubMed ID: 15195212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.
    Ferreira A; Frazão JM; Monier-Faugere MC; Gil C; Galvao J; Oliveira C; Baldaia J; Rodrigues I; Santos C; Ribeiro S; Hoenger RM; Duggal A; Malluche HH;
    J Am Soc Nephrol; 2008 Feb; 19(2):405-12. PubMed ID: 18199805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective randomized multicenter trial of sevelamer hydrochloride and calcium carbonate for the treatment of hyperphosphatemia in hemodialysis patients in Japan.
    Koiwa F; Onoda N; Kato H; Tokumoto A; Okada T; Fukagawa M; Shigematsu T;
    Ther Apher Dial; 2005 Aug; 9(4):340-6. PubMed ID: 16076379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of sevelamer hydrochloride in the Coronary Artery Calcification Index].
    Tsuruta Y; Kaneshiro K; Narita Y; Oobayashi T; Fujii M; Narita M; Sasai K; Yoshimata T; Watanabe Y; Maeda K
    Clin Calcium; 2005 Sep; 15 Suppl 1():200-5. PubMed ID: 16279025
    [No Abstract]   [Full Text] [Related]  

  • 40. Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification.
    Tokumoto M; Mizobuchi M; Finch JL; Nakamura H; Martin DR; Slatopolsky E
    Am J Nephrol; 2009; 29(6):582-91. PubMed ID: 19145073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.